Balanced news tone
News Sentiment
MDCX sentiment intelligence
Medicus Pharma Ltd. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
40 relevant articles
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
-2.1% over one week, +20.7% over four weeks, trend inactive, and below fair value.
Medicus Pharma redesigns Phase 2 trial for 126 patients
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
81/100 classification
One-week reaction
-2.1%
Price reacting lower
Trend fit
Trend inactive
20.7% over four weeks
Fair value
-81.4%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
8
Neutral
32
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
grafa.com
Direct company coverage
Medicus Pharma redesigns Phase 2 trial for 126 patients
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 16:09
- Source
- grafa.com
GuruFocus
Direct company coverage
Medicus Pharma (MDCX) Receives FDA Feedback for Clinical Study
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 13:52
- Source
- GuruFocus
Proactive
Direct company coverage
Medicus Pharma advances Teverelix Phase 2 study after FDA feedback, IRB approval
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 16 Jul 2026 12:37
- Source
- Proactive
MT Newswires
Direct company coverage
Medicus Pharma Receives US FDA Feedback on Potential Acute Urinary Retention Treatment Study
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 12:19
- Source
- MT Newswires
Investing.com India
Direct company coverage
Medicus Pharma receives FDA feedback for optimized Phase 2 study By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 11:38
- Source
- Investing.com India
GlobeNewswire
Direct company coverage
Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention
- Tone
- Positive 58/100
- Event
- Regulatory and legal
- Published
- 16 Jul 2026 11:30
- Source
- GlobeNewswire
Stock Titan
Direct company coverage
Medicus Pharma Expects About 126 Patients in Redesigned Teverelix Study
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 16 Jul 2026 11:30
- Source
- Stock Titan
Moomoo
Direct company coverage
Medicus Pharma (MDCX) Stock Forum and Discussion
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 08:37
- Source
- Moomoo
TradingView
Direct company coverage
Number of shareholders of Medicus Pharma Ltd. – NASDAQ:MDCX
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 09:14
- Source
- TradingView
DirectorsTalk Interviews
Direct company coverage
Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 13 Jul 2026 09:24
- Source
- DirectorsTalk Interviews
DonanımHaber
Direct company coverage
Medicus Pharma Ltd. (MDCX) Slips 3.5% as Stock Nears Critical Support Level - Index Put Call
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 22:47
- Source
- DonanımHaber
ChartMill
Direct company coverage
MDCX Stock Price, Quote & Chart
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 07:00
- Source
- ChartMill
Market source
Direct company coverage
Is Medicus Pharma Ltd. (MDCX) Stock Gaining Momentum With Innovative Skin Cancer Treatment Technology?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
GlobeNewswire
Direct company coverage
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 11:30
- Source
- GlobeNewswire
Stock Titan
Direct company coverage
Medicus brings SkinJect and Teverelix data to Bio 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
Proactive
Direct company coverage
Medicus Pharma advances Teverelix in prostate cancer - ICYMI
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 13:00
- Source
- Proactive
ad-hoc-news.de
Direct company coverage
Eli Lilly Stock - Analyst consensus stays bullish on weight-loss boom
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 20 Jun 2026 07:00
- Source
- ad-hoc-news.de
Fathom Journal
Direct company coverage
This $9 SpaceX Stock Has Crazy Potential Ottawa News (6IhxvTriSq)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:32
- Source
- Fathom Journal
Proactive
Direct company coverage
Medicus Pharma seeks rare pediatric disease tag for SkinJect in Gorlin Syndrome
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 12:47
- Source
- Proactive
MT Newswires
Direct company coverage
Medicus Pharma Seeks FDA Rare Pediatric Disease Designation for SkinJect in Gorlin Syndrome
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 12:07
- Source
- MT Newswires
GlobeNewswire
Direct company coverage
Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 11:30
- Source
- GlobeNewswire
Proactive
Direct company coverage
Medicus Pharma files IND for genomics-enabled endometriosis trial in UAE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 12:50
- Source
- Proactive
Stock Titan
Direct company coverage
Biotech Medicus lands $22M deal, says cash now covers 2+ years
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 28 May 2026 07:00
- Source
- Stock Titan
Finviz
Direct company coverage
BMY - Bristol-Myers Squibb Co Stock Price and Quote
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 14:42
- Source
- Finviz
Finviz
Direct company coverage
AMRN - Amarin Corp ADR Stock Price and Quote
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 14:35
- Source
- Finviz
eciks.org
Direct company coverage
UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+
- Tone
- Positive 84/100
- Event
- Earnings
- Published
- 26 May 2026 07:00
- Source
- eciks.org
Market source
Direct company coverage
Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 19 May 2026 07:00
- Source
- Market source
ad-hoc-news.de
Direct company coverage
Eli Lilly & Co. stock (US5324571083): Q1 revenues surge 56% on obesity drug boom
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de
StockStory
Direct company coverage
GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- StockStory
Seeking Alpha
Direct company coverage
Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- Seeking Alpha